Functional and Structural Assessment of the Effect of Human Umbilical Cord Blood Mesenchymal Stem Cells in Doxorubicin-Induced Cardiotoxicity
- PMID: 28543396
- DOI: 10.1002/jcb.26168
Functional and Structural Assessment of the Effect of Human Umbilical Cord Blood Mesenchymal Stem Cells in Doxorubicin-Induced Cardiotoxicity
Abstract
Cardiomyopathy induced by doxorubicin (DOX) was recognized at an early stage and also several years after drug administration. Mesenchymal stem cells (MSCs) have many properties that make them suitable for preventive and/or regenerative therapies. In this study, we evaluated the effect of MSCs in the functional and the structural improvement of DOX-induced cardiomyopathy in rats. Ninety adult male albino rats were randomly divided into three equal groups of thirty rats each: Group I (control): rats received normal saline. Group II (DOX- group): rats received DOX. Group III (DOX-MSCs group): rats received DOX for 2 weeks then human umbilical cord blood mesenchymal stem cells (hUCB-MSCs). Rats in all groups were evaluated for: physical condition, electrocardiography (ECG), and hemodynamic parameters. Serum cardiac troponin I (cTnI), malondialdehyde (MDA), total antioxidant capacity (TAC), and DNA fragmentation on heart tissue isolated DNA were estimated for evaluation of the mechanism and the extent of the damage. Hearts were examined histopathologically for detection of MSCs homing, structural evaluation, with counting of the collagen fibers for evaluation of fibrosis. DOX-administered rats showed significant functional and structural deterioration. DOX-MSCs treated rats (group III) showed improved functional and structural criteria with restoration of all biochemical indicators of cardiac damage and reactive oxygen species (ROS) to normal, as well. In Conclusion, hUCB-MSCs significantly ameliorated the cardiotoxic manifestations as shown by biochemical, functional, and structural cardiac improvement. J. Cell. Biochem. 118: 3119-3129, 2017. © 2017 Wiley Periodicals, Inc.
Keywords: DOXORUBICIN-INDUCED CARDIOTOXICITY; MESENCHYMAL STEM CELLS; RATS.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Factors enhancing the migration and the homing of mesenchymal stem cells in experimentally induced cardiotoxicity in rats.IUBMB Life. 2017 Mar;69(3):162-169. doi: 10.1002/iub.1600. Epub 2017 Jan 12. IUBMB Life. 2017. PMID: 28083978
-
Umbilical cord blood-mesenchymal stem cells and carvedilol reduce doxorubicin- induced cardiotoxicity: Possible role of insulin-like growth factor-1.Biomed Pharmacother. 2018 Sep;105:1192-1204. doi: 10.1016/j.biopha.2018.06.051. Epub 2018 Jun 21. Biomed Pharmacother. 2018. PMID: 30021356
-
Mesenchymal stem cells pretreated with platelet-rich plasma modulate doxorubicin-induced cardiotoxicity.Hum Exp Toxicol. 2019 Jul;38(7):857-874. doi: 10.1177/0960327119842613. Epub 2019 Apr 16. Hum Exp Toxicol. 2019. PMID: 30991846
-
Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?Tissue Eng Part B Rev. 2014 Oct;20(5):523-44. doi: 10.1089/ten.TEB.2013.0664. Epub 2014 Apr 22. Tissue Eng Part B Rev. 2014. PMID: 24552279 Review.
-
Cardioprotective effects of exercise training on doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis of preclinical studies.Sci Rep. 2021 Mar 18;11(1):6330. doi: 10.1038/s41598-021-83877-8. Sci Rep. 2021. PMID: 33737561 Free PMC article.
Cited by
-
LncRNA GHET1 from bone mesenchymal stem cell-derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3.Sci Rep. 2024 Aug 17;14(1):19078. doi: 10.1038/s41598-024-70151-w. Sci Rep. 2024. PMID: 39154102 Free PMC article.
-
A Study of the Effects of Doxorubicin-Containing Liposomes on Osteogenesis of 3D Stem Cell Spheroids Derived from Gingiva.Materials (Basel). 2019 Aug 23;12(17):2693. doi: 10.3390/ma12172693. Materials (Basel). 2019. PMID: 31443583 Free PMC article.
-
Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate.Front Pharmacol. 2019 Jun 14;10:635. doi: 10.3389/fphar.2019.00635. eCollection 2019. Front Pharmacol. 2019. PMID: 31258475 Free PMC article. Review.
-
Infusion of two-dose mesenchymal stem cells is more effective than a single dose in a dilated cardiomyopathy rat model by upregulating indoleamine 2,3-dioxygenase expression.Stem Cell Res Ther. 2022 Aug 12;13(1):409. doi: 10.1186/s13287-022-03101-w. Stem Cell Res Ther. 2022. PMID: 35962420 Free PMC article.
-
Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review.Biomedicines. 2020 Dec 5;8(12):570. doi: 10.3390/biomedicines8120570. Biomedicines. 2020. PMID: 33291410 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials